Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis

British Journal of Haematology

Volumn 110, Issue 2, 2000, Pages 454-460

  Mumford, Andrew D ^a   O’donnell, James ^a   Gillmore, Julian D ^b   Manning, Richard A ^a   Hawkins, Philip N ^b   Laffan, Michael ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

AL amyloidosis; Factor X deficiency; Fibrin polymerization; Serum amyloid P scintigraphy; Thrombin time

Indexed keywords

AMYLOID; BLOOD CLOTTING FACTOR 10; IMMUNOGLOBULIN LIGHT CHAIN;

ALBUMIN BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CONTROLLED STUDY; DISEASE ACTIVITY; FIBRIN POLYMERIZATION; HUMAN; LIVER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEINURIA; PROTHROMBIN TIME; SCINTIGRAPHY; THROMBIN TIME;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BLOOD COAGULATION DISORDERS; FACTOR X DEFICIENCY; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPHROTIC SYNDROME; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBIN TIME;

EID: 0033845162     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02183.x     Document Type: Article

References (19)

1. The prolonged thrombin time of nephrotic syndrome
2. Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses
3. Syndrome of acquired factor X deficiency and systemic amyloidosis in vivo studies of the metabolic fate of factor X
4. Mechanism of factor X deficiency in systemic amyloidosis
5. Inhibitor of the thrombin time in systemic amyloidosis: A common coagulation abnormality
6. AL amyloidosis combined with acquired factor V deficiency
7. Factor X deficiency and systemic amyloidosis
8. Factor X deficiency in amyloidosis: A critical review
9. Acquired factor X deficiency in a patient with amyloidosis
10. Amyloidosis (AL): Clinical and laboratory features of 229 cases
11. Increased fibrinolysis and amyloidosis
12. Coagulopathy in amyloidosis: Combined deficiencies of factor X and IX
13. Enhanced blood coagulation and fibrinolysis in a patient with primary amyloidosis
14. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: Regression of visceral amyloid following liver transplantation
15. Carbohydrate residues modulate the activation of coagulation factor X
16. Circulating heparin-like anticoagulants: Report of five consecutive cases and a review
17. Fibrin polymerisation defect in HIV-infected patients - Evidence for a critical role of albumin in the prolongation of thrombin and reptilase times
18. Inhibition or acceleration of fibrin polymerisation by monoclonal immunoglobulins and immunoglobulin fragments
19. Bleeding manifestations in 100 patients with amyloidosis